Slowing of gastric emptying contributes to the glucose-lowering effect of exogenous GLP-1 in health, type-2 diabetics, and critically ill patients following an intragastric 'meal' [9,18,19]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.